• Allogene Therapeutics, Inc.

210 East Grand Avenue
South San Francisco, CA 94080
United States
Website

  • Recently Viewed
  • Symbol Price

Price

Last Close
$ 15.74 ( +0.01 )
Trading Volume
1,424,000
Market Cap
$ 1.9B
52-Week High/Low
$13.43 - $39.02

Earnings

2020 2021
$ -0.53 $ -0.25
P/E Ratio
Trailing Forward
$ 0 -
2020 P/E Ratio
Trailing Forward
$ 0 -
2020 P/E Ratio
Trailing Forward
$ 0 $ -

Gain

30-day
ALLO -38.024%
S&P 500 4.06%
90-day
-30.55%
3.87%

180-day

-54.76%
8.42%

52-Week

-58.01%
31.69%

Dividend

Dividend
$0
Dividend Yield
0%
Outstanding
121,483,000
50 Day Avg Volume
6354971

Calendar

Fiscal Year End
Dec 31
Last Earning Date
Nov 02, 2021
Ex-Dividend Date
-
Current Year Beta
1.06

Ratio

Debt to Equity
0
Return on Equity
0
Price to Cash Flow
-

Returns +
Q

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Q1 39.2% -25.2% 7.4% - - - - - - - -
Q2 -25.9% 120.3% -7.3% - - - - - - - -
Q3 -1.1% -11.9% -3.3% - - - - - - - -
Q4 -39% -33% -4.6% 7.7% - - - - - - -

Returns +
M

J F M A M J J A S O N D
2021 42.9% -3.9% 1.4% -12.1% -16.9% 1.5% -15.8% 8.7% 8.1% -39% - -
2020 -17.3% 20.3% -24.8% 48.7% 66.6% -11.1% -14.4% -4.1% 7.2% -8.4% -11.1% -17.7%

Returns +
A

    2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
    -38%-3%-4%0%0%0%0%0%0%0%0%

52 Week High/Low

Annual Earnings

Earnings

2021 2020 2019 2018 2017 2016 2015
Q1 -0.25 -0.5 -0.32 -0.1 - - -
Q2 -0.53 -0.53 -0.41 -43.82 - - -
Q3 - -0.52 -0.5 -10.71 - - -
Q4 - -0.53 -0.6 -0.37 - - -
A -0.8 -2.08 -1.8

Dividend +

Q1
Q2
Q3
Q4
A

Chart +